Lynch TJ - Search Results

1

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.

Ter-Minassian M, Zhai R, Asomaning K, Su L, Zhou W, Liu G, Heist RS, Lynch TJ, Wain JC, Lin X, De Vivo I, Christiani DC. Ter-Minassian M, et al. Among authors: lynch tj. Carcinogenesis. 2008 Nov;29(11):2147-52. doi: 10.1093/carcin/bgn205. Epub 2008 Aug 29. Carcinogenesis. 2008. PMID: 18757527 Free PMC article.

2

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111

3

Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms.

Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Among authors: lynch tj. Epidemiology. 2003 Sep;14(5):545-51. doi: 10.1097/01.ede.0000073120.46981.24. Epidemiology. 2003. PMID: 14501269

4

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC. Gurubhagavatula S, et al. Among authors: lynch tj. J Clin Oncol. 2004 Jul 1;22(13):2594-601. doi: 10.1200/JCO.2004.08.067. Epub 2004 Jun 1. J Clin Oncol. 2004. PMID: 15173214 Clinical Trial.

5

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Clin Cancer Res. 2004 Aug 1;10(15):4939-43. doi: 10.1158/1078-0432.CCR-04-0247. Clin Cancer Res. 2004. PMID: 15297394

6

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: lynch tj. Cancer Lett. 2004 Oct 8;214(1):69-79. doi: 10.1016/j.canlet.2004.06.027. Cancer Lett. 2004. PMID: 15331175

7

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.

Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: lynch tj. Cancer. 2004 Dec 15;101(12):2802-8. doi: 10.1002/cncr.20716. Cancer. 2004. PMID: 15534883 Free article.

8

Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.

Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):491-6. doi: 10.1158/1055-9965.EPI-04-0612. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734977

9

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, Lynch TJ, Wain JC, Neuberg D, Liu G, Christiani DC. Suk R, et al. Among authors: lynch tj. Clin Cancer Res. 2005 Feb 15;11(4):1534-8. doi: 10.1158/1078-0432.CCR-04-1953. Clin Cancer Res. 2005. PMID: 15746057

10

Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.

Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):567-70. doi: 10.1158/1055-9965.EPI-04-0482. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page